UpdatesGeneral Updates

Aurobindo Pharma's US subsidiary, Lannett Company, concluded a US FDA inspection with four procedural observations.

Aurobindo Pharma Limited logo
Aurobindo Pharma LimitedAUROPHARMA · Filed with the exchange

The company will respond promptly, reinforcing its commitment to robust quality and compliance standards.

Read the original filing(PDF)

No comments yet. Be the first.

More from Aurobindo Pharma Limited

All announcements